{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:04:07Z","timestamp":1790309047250,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1136\/ijgc-00009577-200605000-00032","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T12:28:03Z","timestamp":1551875283000},"page":"1157-1164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix"],"prefix":"10.1016","volume":"16","author":[{"given":"C.H.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-G.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-S.","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1200\/JCO.1985.3.8.1079","article-title":"Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"3","author":"Bonomi","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0090-8258(89)80033-2","article-title":"A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study","volume":"32","author":"Thigpen","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0015","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO;2-6","article-title":"Cisplatinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group","volume":"48","author":"Thigpen","year":"1981","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0020","first-page":"903","article-title":"Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group","volume":"69","author":"Picozzi","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0025","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-0528.1987.tb02323.x","article-title":"Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervix","volume":"94","author":"Rustin","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1438.1991.tb00019.x","article-title":"Cisplatin, methotrexate and bleomycin (PMB) for carcinoma of the cervix: the influence of presentation and previous treatment upon response","volume":"1","author":"Hoskin","year":"1991","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.1997.15.1.165","article-title":"Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"15","author":"Omura","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1200\/JCO.1996.14.3.792","article-title":"Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study","volume":"14","author":"McGuire","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0045","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.1999.17.3.761","article-title":"Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix","volume":"17","author":"Papadimitriou","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"58","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0169-2607(88)90086-7","article-title":"Micro-computer-assisted univariate survival data analysis using Kaplan-Meier life table estimators","volume":"27","author":"Campos-Filho","year":"1988","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0065","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/1097-0142(19890401)63:7<1283::AID-CNCR2820630709>3.0.CO;2-U","article-title":"Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin","volume":"63","author":"Potter","year":"1989","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/gyno.1997.4812","article-title":"Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results","volume":"67","author":"Sardi","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0075","first-page":"447","article-title":"Three-year results after neoadjuvant chemotherapy, radical surgery, and radiotherapy in locally advanced cervical carcinoma","volume":"82","author":"Zanetta","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/gyno.1995.1183","article-title":"Factors predicting response to chemotherapy and survival in patients with metastatic or recurrent squamous cell cervical carcinoma: a multivariate analysis","volume":"58","author":"Zanetta","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1525-1438.1993.03030129.x","article-title":"The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review","volume":"3","author":"Vermorken","year":"1993","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0090","first-page":"267","article-title":"A randomized trial of cisplatin (C) versus C 1 mitolactol (CM) versus C 1 ifosfamide (CIFX) in advanced squamous carcinoma of the cervix (SCC) by the Gynecologic Oncology Group (GOG)","volume":"14","author":"Omura","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0095","first-page":"115","article-title":"Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose","volume":"23","author":"Cerrotta","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0100","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2005.04.172","volume":"23","author":"Buda","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/gyno.1999.5586","article-title":"Firstline chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix\u2014a phase II study","volume":"75","author":"Piver","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0110","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1200\/JCO.1999.17.9.2676","article-title":"Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study","volume":"17","author":"Rose","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0115","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/gyno.2002.6649","article-title":"Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group","volume":"85","author":"Dimopoulos","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0120","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1023\/A:1008362814642","article-title":"Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer","volume":"10","author":"Zanetta","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0130","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.1998.16.5.1879","article-title":"Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design","volume":"16","author":"Brader","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1023\/A:1011165115426","article-title":"Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study","volume":"12","author":"Vermorken","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/gyno.1993.1084","article-title":"Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"49","author":"Sutton","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0145","first-page":"1097","article-title":"Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study","volume":"70","author":"Thigpen","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0150","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2001.19.5.1275","article-title":"Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study","volume":"19","author":"Curtin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/bjc.1997.125","article-title":"Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study","volume":"75","author":"Veldhuis","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-00009577-200605000-00032_bb0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/gyno.1996.0210","article-title":"Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity","volume":"62","author":"Connelly","year":"1996","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24033401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24033401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200605000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:16:42Z","timestamp":1753233402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24033401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":32,"aliases":["10.1111\/j.1525-1438.2006.00549.x"],"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1048891X24033401"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200605000-00032","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200605000-00032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2006 Blackwell Publishing Ltd.","name":"copyright","label":"Copyright"}]}}